Skip to Content

Valproic Acid [BSA]

Valproic Acid, BSAconjugated DAG3422 chemosynchetic Lot. No. (See product label) PRODUCT INFORMATION Product overview Valproic Acid, BSAconjugated Description Valproic Acid, Conjugated Species chemosynchetic Source Valproic Acid conjugated with bovine serum albumin (BSA). Conjugate BSA Form Liquid; 0.01M PBS,PH7.4 Quality Control Test 1 milligram PACKAGING Storage Store at 20°C for one year. BACKGROUND Introduction Valproic acid, valproate sodium and divalproex belong to the group of medicines called anticonvulsants, used to control certain types of seizures in the treatment of epilepsy. Also, valproic acid relieves histone deacetylases (HDACs) dependent transcriptional repression and causes hyperacetylation of histones in cultured cells and in vivo. Valproic acid inhibits HDAC activity in vitro, most probably by binding to the catalytic centre of HDACs. Most importantly, valproic acid induces differentiation of carcinoma cells, transformed haematopoietic progenitor cells and leukaemic blasts from acute myeloid leukaemia patients. Moreover, tumour growth and metastasis formation are significantly reduced in animal experiments. Therefore, valproic acid might serve as an effective drug for cancer therapy. Keywords Valproic acid; VPA; Convulex; Depakene; Epilim; Ergenyl; Mylproin; valproate; Valproesαure; Valproic Creative Diagnostics. All rights reserved 4516 Ramsey Road Shirley, NY 11967, USA Tel: 6316244882 ·Fax:6316147828 Email: info@creativediagnostics.com www.creativediagnostics.com
SKU: CDX-DAG3422-1mg
Supplier: Creative Diagnostics
Unit: mg
Price
POA 0.00 € 0.00 €
 Terms and Conditions